PUMA Welcomes Athletes to Budapest Ahead of World Athletics Championships
19.8.2023 13:48:00 EEST | Business Wire | Press release
Sports company PUMA has kicked off its celebrations for the World Athletics Championships in style, welcoming athletes and media from around the world to the official opening of the PUMA House.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230819043891/en/
Sports company PUMA has kicked off its celebrations for the World Athletics Championships in style, welcoming athletes, and media from around the world to the official opening of the PUMA House. Maria Valdes (Chief Product Officer at PUMA) and Erin Longin (General Manager, Run/Train) took to the stage alongside PUMA ambassadors, and icons of track and field including Karsten Warholm, Marcell Jacobs, Julien Alfred, Mutaz Barshim and Pia Skrzyszowska, giving insight on their preparations and expectations for the competition. Guests were also given the opportunity to hear from Jamaican athletes Shericka Jackson, Rasheed Broadbell, Hansle Parchment, and rising star Jaydon Hibbert. Watch the highlights video on PUMA YouTube. (Photo: Business Wire)
Maria Valdes (Chief Product Officer at PUMA) and Erin Longin (General Manager, Run/Train) took to the stage alongside PUMA ambassadors, and icons of track and field including Karsten Warholm, Marcell Jacobs, Julien Alfred, Mutaz Barshim and Pia Skrzyszowska, giving insight on their preparations and expectations for the competition.
Maria Valdes said: “2023 is a great year for us - it’s our 75th year anniversary – and we truly believe that track and field is the root of many sports. There are so many memorable moments we can look back on where track and field really represented our brand. From Tommie Smith back in 1968 to the numerous world records of Bolt just a couple of years ago. We hope to have more moments like this that can help shape us for years to come – starting here in Budapest.”
Karsten Warholm said: “Confidence is something you build. Obviously, it's not a given. If it is, it's not real. We prepare very well in training, and I think that is the secret to my confidence. My coach takes good care of me and the way we work, we always have control. And then of course when you go to a World Championship, you never know what you can pull out of the hat.”
Marcell Jacobs said: “Maybe I had too many injuries in the last two years… I really tried to overcome all of those problems. I'm the one who wants to be in a good shape, perfectly fit, and ready to face this very important challenge at the World Championships in Budapest.“
Julien Alfred said: “It's been fantastic to be part of the Puma family. Puma is a great brand who have paved the way for many of my idols and it feels great. And I really love the spikes as well!“
Guests were also given the opportunity to hear from Jamaican athletes Shericka Jackson, Rasheed Broadbell, Hansle Parchment, and rising star Jaydon Hibbert.
Shericka Jackson said: “I've been working hard and there is no pressure for me. I'm in good shape and I'm going to show up, stay in my lane and focus on me.“
Rasheed Broadbell said: “It's really not a bad feeling [to not be the favourite], but a good thing, because the attention is not on me, so it's not really much pressure… But whoever the eyes is on, they have to ensure that they deliver. So for me, it's just keeping in my lane, stay focused and deliver.“
Hansle Parchment said: “Usually everybody is going to the US for college, but at the last minute we changed our minds to go to the University of the West Indies. I think that was a very good decision for me, otherwise I would have been running every weekend in the US. I'm very happy that I made that decision to stay in Jamaica.”
The World Athletics Championship Budapest 2023 will take place from 19-27 August.
Video:
To watch the full press conference – click here
To download the full press conference – click here
To watch the highlight video – click here
Images:
PUMA House imagery – click here
PUMA
PUMA is one of the world’s leading sports brands, designing, developing, selling and marketing footwear, apparel and accessories. For 75 years, PUMA has relentlessly pushed sport and culture forward by creating fast products for the world’s fastest athletes. PUMA offers performance and sport-inspired lifestyle products in categories such as Football, Running and Training, Basketball, Golf, and Motorsports. It collaborates with renowned designers and brands to bring sport influences into street culture and fashion. The PUMA Group owns the brands PUMA, Cobra Golf and stichd. The company distributes its products in more than 120 countries, employs about 20,000 people worldwide, and is headquartered in Herzogenaurach/Germany.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230819043891/en/
Contact information
Media Contact: Stefan.Popovic@Puma.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 17:18:00 EEST | Press release
Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 15:30:00 EEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 14:45:00 EEST | Press release
Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom